Diab, Sami
Université Libre de Bruxelles · University of California, Los Angeles · Institut Jules Bordet · Massachusetts General Hospital · Institut universitaire du cancer de Toulouse Oncopole · Dana-Farber Cancer Institute · Institut Claudius Regaud · Rocky Mountain Cancer Centers · UCLA Jonsson Comprehensive Cancer Center · Institut Curie
2 papers on CoChat
Most cited papers
- Verified
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Bardia, A., Hurvitz, S. A., Tolaney, S. M., Loirat, D., Punie, K., Oliveira, M., Brufsky, A., Sardesai, S. D., Kalinsky, K., Zelnak, A. B., et al. (2021) · New England Journal of Medicine
Breast Cancer Treatment StudiesCancer Treatment and Pharmacology
Cited by 1,711
- Verified
Abstract CT071: Talazoparib (TALA) in germline BRCA1/2 (g BRCA1/2)-mutated human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (ABC): Final overall survival (OS) results from randomized Phase 3 EMBRACA trial
Litton, J. K., Hurvitz, S. A., Mina, L. A., Rugo, H. S., Lee, K.-H., Gonçalves, A., Diab, S., Woodward, N., Goodwin, A., Yerushalmi, R., et al. (2020) · Cancer Research
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free